Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,589,160
-
Share change
-
-763,337
-
Total reported value
-
$18,432,000
-
Put/Call ratio
-
0%
-
Price per share
-
$2.15
-
Number of holders
-
50
-
Value change
-
-$1,804,146
-
Number of buys
-
18
-
Number of sells
-
26
Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q1 2015
As of 31 Mar 2015,
ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,589,160 shares.
The largest 10 holders included
BVF INC/IL, Allianz Asset Management AG, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, TANG CAPITAL MANAGEMENT LLC, Abingworth LLP, FMR LLC, VANGUARD GROUP INC, Connor, Clark & Lunn Investment Management Ltd., and BlackRock Group LTD.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.